Analyst Consensus ?
ConsensusHold68 ratings
Bullish2638.2%
Neutral3551.5%
Bearish710.3%
1 unmapped firm rating excluded from the percentages.
Lululemon Athletica Inc. · LULU · FY2026 Q2 · Calendar Q3 2026
Lululemon lowers FY2026 outlook as North America weakens
The quarter weakens the case for near-term earnings growth: revenue declined and FY2026 guidance was lowered, while management's product, replenishment, marketing, and store actions are intended to restore full-price demand. Evidence for a recovery includes strength in away-from-body styles, planned product launches, and international expansion; evidence against it includes North American weakness, softer traffic and conversion, and continued margin and brand-sentiment risks.
Reported After market closeNASDAQConsumer Cyclical
$11.14B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$2.92
Consensus $1.79
EPS surprise
+63.1%
Reported versus consensus
Reported revenue
$2.42B
Consensus $2.46B
Revenue surprise
-1.7%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
-17.4%
Event window
SPY move
-0.4%
Same window
Abnormal move
-17.0%
Stock minus SPY
Volume
8.7×
Versus trailing sessions
Subsequent drift
-2.5%
Up to 20 sessions
LULUSPY benchmark
Ask FN2 about LULU FY2026 Q2
Transcript, numbers and history already loaded
Why did LULU fall 17.4% after beating EPS estimates in FY2026 Q2?What changed in LULU's guidance and outlook in FY2026 Q2?Give me the bull and bear case for LULU after FY2026 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, management reported a deeper revenue decline and again lowered FY2026 guidance. The response remains focused on SKU reduction, faster chase, marketing, store optimization, and product innovation; tariff refunds improved gross margin in the latest quarter, but ongoing pressure is expected.
Guidance delta
FY2026 guidance was lowered. Management also expects continued overall margin pressure despite gross-margin help from tariff refunds.
Key takeaways
- Q2 revenue declined 4% year over year to $2.4 billion, with North America down 8% and modest growth in China Mainland.
- Management is responding with SKU reductions, faster chase capability, store optimization, increased marketing, and product launches.
- Tariff refunds supported gross margin this quarter, but softer traffic, conversion pressure, and brand-sentiment issues remain material risks.
Management priorities
- Reduce SKU count by about 15% and continue store-layout redesigns.
- Increase chase volume and improve replenishment of high-demand styles.
- Invest in mid-funnel creator content, community events, and international partnerships.
- Open about 35 net new company-operated stores in 2026 while trimming capital spending.
Follow LULU with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$98.06Previous close
$70Low
$312.32Average
$542High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 21, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Argus Research | Hold | Hold | Maintain | Sep 14, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Sep 9, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Sep 4, 2026 |
| UBS | Neutral | Neutral | Maintain | Sep 4, 2026 |
| Truist Securities | Sell | Sell | Maintain | Sep 4, 2026 |
| Telsey Advisory Group | Market Perform | Market Perform | Maintain | Sep 4, 2026 |
| Stifel | Hold | Hold | Maintain | Sep 4, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Sep 4, 2026 |
| Needham | Hold | Hold | Maintain | Sep 4, 2026 |
| Morgan Stanley | Underweight | Underweight | Maintain | Sep 4, 2026 |
| Keybanc | Sector Weight | Maintain | Sep 4, 2026 | |
| JP Morgan | Neutral | Neutral | Maintain | Sep 4, 2026 |
| Guggenheim | Neutral | Neutral | Maintain | Sep 4, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Sep 4, 2026 |
| BTIG | Neutral | Neutral | Maintain | Sep 4, 2026 |
| BNP Paribas | Underperform | Underperform | Maintain | Sep 4, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Sep 4, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Sep 4, 2026 |
| Baird | Neutral | Neutral | Maintain | Sep 4, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Sep 4, 2026 |
| Jefferies | Hold | Hold | Maintain | Jun 5, 2026 |
| Freedom Broker | Hold | Sell | Upgrade | Jun 5, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Jun 5, 2026 |
| HSBC | Hold | Buy | Downgrade | Sep 11, 2025 |
| William Blair | Market Perform | Outperform | Downgrade | Sep 5, 2025 |
| Oppenheimer | Perform | Outperform | Downgrade | Sep 5, 2025 |
| CICC | Market Perform | Outperform | Downgrade | Jun 9, 2025 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jun 6, 2025 |
| Raymond James | Market Perform | Outperform | Downgrade | Mar 28, 2025 |
| Deutsche Bank | Hold | Hold | Maintain | Dec 9, 2024 |
| TD Cowen | Buy | Buy | Maintain | Aug 30, 2024 |
| Wedbush | Outperform | Outperform | Maintain | Aug 28, 2024 |
| Exane BNP Paribas | Underperform | Neutral | Downgrade | Feb 9, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Mar 29, 2023 |
| TD Securities | Outperform | Outperform | Maintain | Mar 24, 2023 |
| Redburn Partners | Sell | Sell | Maintain | Mar 16, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Dec 5, 2022 |
| B. Riley Securities | Buy | Buy | Maintain | Jun 3, 2022 |
| MKM Partners | Buy | Buy | Maintain | Sep 7, 2021 |
| RBC Capital | Outperform | Outperform | Maintain | Mar 31, 2021 |
| B. Riley FBR | Buy | Buy | Maintain | Aug 18, 2020 |
| B. Riley | Buy | Neutral | Upgrade | Apr 3, 2020 |
| CFRA | Buy | Buy | Maintain | Mar 27, 2020 |
| PiperJaffray | Overweight | Overweight | Maintain | Dec 12, 2019 |
| Bank of America | Buy | Buy | Maintain | Dec 9, 2019 |
| Piper Jaffray | Overweight | Overweight | Maintain | Sep 23, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jun 13, 2019 |
| Canaccord Genuity | Buy | Buy | Maintain | Jun 13, 2019 |
| Macquarie | Neutral | Underperform | Upgrade | May 7, 2019 |
| DA Davidson | Neutral | Neutral | Maintain | Mar 28, 2019 |
| Nomura | Neutral | Buy | Downgrade | Feb 19, 2019 |
| Buckingham Research | Buy | Neutral | Upgrade | Jan 9, 2019 |
| Buckingham | Buy | Neutral | Upgrade | Jan 9, 2019 |
| Argus | Buy | Hold | Upgrade | Aug 16, 2018 |
| Susquehanna | Positive | Neutral | Upgrade | Sep 5, 2017 |
| CLSA | Underperform | Underperform | Maintain | Jan 19, 2017 |
| FBR Capital | Market Perform | Underperform | Upgrade | Dec 12, 2016 |
| Mizuho | Buy | Neutral | Upgrade | Dec 8, 2016 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jun 9, 2016 |
| Wolfe Research | Perform | Peer Perform | Maintain | Aug 17, 2015 |
| Sterne Agee | Buy | Neutral | Upgrade | Apr 8, 2015 |
| Brean Capital | Buy | Buy | Maintain | Oct 23, 2014 |
| D.A. Davidson | Neutral | Buy | Downgrade | Aug 28, 2014 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Jan 27, 2014 |
| Janney Capital | Neutral | Buy | Downgrade | Jan 27, 2014 |
| ISI Group | Neutral | Strong Buy | Downgrade | Jan 20, 2014 |
| Topeka | Buy | Buy | Maintain | Dec 19, 2013 |
| Credit Agricole | Underperform | Sell | Maintain | Jun 7, 2013 |
| Auriga | Buy | Buy | Maintain | Mar 14, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $98.06. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| BMO Capital | Analyst unavailable | $70 | $103.19 | -28.6% | Sep 8, 2026 |
| Bernstein | Aneesha Sherman | $115 | $121.77 | +17.3% | Sep 4, 2026 |
| Robert W. Baird | Analyst unavailable | $115 | $121.77 | +17.3% | Sep 4, 2026 |
| Stifel Nicolaus | Analyst unavailable | $100 | $121.77 | +2.0% | Sep 4, 2026 |
| Piper Sandler | Analyst unavailable | $80 | $121.77 | -18.4% | Sep 4, 2026 |
| Morgan Stanley | Alex Straton | $83 | $121.77 | -15.4% | Sep 4, 2026 |
| UBS | Jay Sole | $106 | $121.77 | +8.1% | Sep 4, 2026 |
| Wells Fargo | Ike Boruchow | $95 | $121.77 | -3.1% | Sep 4, 2026 |
| Goldman Sachs | Brooke Roach | $111 | $117.39 | +13.2% | Aug 26, 2026 |
| UBS | Jay Sole | $120 | $117.73 | +22.4% | Aug 25, 2026 |
| Truist Financial | Analyst unavailable | $94 | $117.42 | -4.1% | Jul 16, 2026 |
| Morgan Stanley | Analyst unavailable | $93 | $113.49 | -5.2% | Jul 6, 2026 |
| Truist Financial | Joseph Civello | $115 | $116.05 | +17.3% | Jun 5, 2026 |
| BNP Paribas | Analyst unavailable | $88 | $124.92 | -10.3% | Jun 5, 2026 |
| Bernstein | Analyst unavailable | $145 | $124.92 | +47.9% | Jun 5, 2026 |
| Piper Sandler | Anna Andreeva | $110 | $114.71 | +12.2% | Jun 5, 2026 |
| Stifel Nicolaus | Peter McGoldrick | $134 | $124.92 | +36.7% | Jun 5, 2026 |
| Wells Fargo | Ike Boruchow | $110 | $124.92 | +12.2% | Jun 5, 2026 |
| Jefferies | Analyst unavailable | $115 | $124.92 | +17.3% | Jun 5, 2026 |
| Wells Fargo | Analyst unavailable | $140 | $124.92 | +42.8% | Jun 5, 2026 |
| Piper Sandler | Anna Andreeva | $130 | $126.33 | +32.6% | May 22, 2026 |
| BTIG | Janine Stichter | $250 | $162.79 | +154.9% | Mar 12, 2026 |
| Deutsche Bank | Analyst unavailable | $228 | $212.2 | +132.5% | Jan 8, 2026 |
| UBS | Jay Sole | $206 | $210.67 | +110.1% | Dec 31, 2025 |
| Piper Sandler | Anna Andreeva | $190 | $204.62 | +93.8% | Dec 12, 2025 |
| Robert W. Baird | Analyst unavailable | $210 | $187.06 | +114.2% | Dec 12, 2025 |
| Stifel Nicolaus | Analyst unavailable | $210 | $187.06 | +114.2% | Dec 12, 2025 |
| Jefferies | Randal Konik | $170 | $187.06 | +73.4% | Dec 12, 2025 |
| BTIG | Janine Stichter | $303 | $169.67 | +209.0% | Nov 25, 2025 |
| UBS | Analyst unavailable | $183 | $170.68 | +86.6% | Nov 17, 2025 |
| Jefferies | Analyst unavailable | $120 | $178.17 | +22.4% | Oct 27, 2025 |
| BNP Paribas | Analyst unavailable | $146 | $167.41 | +48.9% | Oct 20, 2025 |
| Robert W. Baird | Mark Altschwager | $195 | $173.41 | +98.9% | Sep 23, 2025 |
| Truist Financial | Analyst unavailable | $170 | $167.8 | +73.4% | Sep 5, 2025 |
| Robert W. Baird | Mark Altschwager | $225 | $167.8 | +129.5% | Sep 5, 2025 |
| Piper Sandler | Anna Andreeva | $165 | $167.8 | +68.3% | Sep 5, 2025 |
| Evercore ISI | Analyst unavailable | $180 | $167.8 | +83.6% | Sep 5, 2025 |
| Stifel Nicolaus | Peter McGoldrick | $205 | $167.8 | +109.1% | Sep 5, 2025 |
| Needham | Analyst unavailable | $430 | $337.24 | +338.5% | Mar 26, 2025 |
| Needham | Tom Nikic | $475 | $395.47 | +384.4% | Jan 10, 2025 |
| Bernstein | Lululemon to Outperform | $460 | $393.46 | +369.1% | Jan 7, 2025 |
| Deutsche Bank | Krisztina Katai | $396 | $399.6 | +303.8% | Dec 9, 2024 |
| Oppenheimer | Brian Nagel | $380 | $316.44 | +287.5% | Nov 27, 2024 |
| Robert W. Baird | Mark Altschwager | $380 | $318.81 | +287.5% | Nov 6, 2024 |
| Truist Financial | Scot Ciccarelli | $360 | $318.81 | +267.1% | Nov 5, 2024 |
| Piper Sandler | Anna Andreeva | $260 | $303.61 | +165.1% | Oct 30, 2024 |
| KeyBanc | Matthew Boss | $338 | $285.32 | +244.7% | Oct 14, 2024 |
| KeyBanc | Ashley Owens | $350 | $279.25 | +256.9% | Oct 14, 2024 |
| Barclays | Adrienne Yih | $261 | $278.24 | +166.2% | Oct 14, 2024 |
| Robert W. Baird | Mark Altschwager | $350 | $253.7 | +256.9% | Sep 6, 2024 |
| Raymond James | Rick Patel | $350 | $270.91 | +256.9% | Aug 27, 2024 |
| Jefferies | Randal Konik | $220 | $271 | +124.4% | Aug 27, 2024 |
| Morgan Stanley | Alex Straton | $329 | $271.1 | +235.5% | Aug 26, 2024 |
| Goldman Sachs | Brooke Roach | $286 | $240 | +191.7% | Aug 2, 2024 |
| Truist Financial | Scot Ciccarelli | $310 | $247.32 | +216.1% | Jul 25, 2024 |
| Citigroup | Paul Lejuez | $300 | $272.06 | +205.9% | Jul 25, 2024 |
| Deutsche Bank | Krisztina Katai | $357 | $309.81 | +264.1% | Jun 12, 2024 |
| Bernstein | Aneesha Sherman | $382 | $317.86 | +289.6% | Jun 7, 2024 |
| BMO Capital | Simeon Siegel | $384 | $316.13 | +291.6% | Jun 6, 2024 |
| HSBC | Akshay Gupta | $425 | $316.62 | +333.4% | Jun 6, 2024 |
| CFRA | Zachary Warring | $435 | $308.27 | +343.6% | Jun 6, 2024 |
| Wells Fargo | Ike Boruchow | $350 | $308.27 | +256.9% | Jun 6, 2024 |
| KeyBanc | Ashley Owens | $415 | $316.08 | +323.2% | Jun 6, 2024 |
| Wedbush | Tom Nikic | $397 | $304.39 | +304.9% | Jun 5, 2024 |
| Morgan Stanley | Alex Straton | $404 | $295.25 | +312.0% | May 29, 2024 |
| BTIG | Janine Stichter | $425 | $295.25 | +333.4% | May 29, 2024 |
| UBS | Jay Sole | $385 | $299.63 | +292.6% | May 22, 2024 |
| Barclays | Adrienne Yih | $395 | $322.98 | +302.8% | May 22, 2024 |
| Robert W. Baird | Mark Altschwager | $505 | $347.51 | +415.0% | Apr 19, 2024 |
| Piper Sandler | Abbie Zvejnieks | $470 | $360.46 | +379.3% | Apr 9, 2024 |
| Oppenheimer | Brian Nagel | $445 | $357.56 | +353.8% | Apr 5, 2024 |
| Jefferies | Randal Konik | $240 | $374.01 | +144.7% | Apr 4, 2024 |
| Barclays | Adrienne Yih | $546 | $388.9 | +456.8% | Mar 25, 2024 |
| Wedbush | Tom Nikic | $492 | $408.17 | +401.7% | Mar 22, 2024 |
| BMO Capital | Simeon Siegel | $420 | $403.19 | +328.3% | Mar 22, 2024 |
| Needham | Anna Andreeva | $500 | $403.19 | +409.9% | Mar 22, 2024 |
| Piper Sandler | Abbie Zvejnieks | $525 | $403.19 | +435.4% | Mar 22, 2024 |
| Stifel Nicolaus | Jim Duffy | $539 | $403.19 | +449.7% | Mar 22, 2024 |
| Wells Fargo | Ike Boruchow | $425 | $403.19 | +333.4% | Mar 22, 2024 |
| Truist Financial | Joseph Civello | $500 | $423.98 | +409.9% | Nov 17, 2023 |
| Telsey Advisory | Dana Telsey | $450 | $390.29 | +358.9% | Sep 21, 2023 |
| Needham | Anna Andreeva | $470 | $395.68 | +379.3% | Sep 20, 2023 |
| Guggenheim | Robert Drbul | $440 | $398.28 | +348.7% | Sep 1, 2023 |
| Morgan Stanley | Alex Straton | $424 | $369.32 | +332.4% | Jun 2, 2023 |
| Loop Capital Markets | Noah Zatzkin | $400 | $365.44 | +307.9% | Jun 2, 2023 |
| Telsey Advisory | Dana Telsey | $425 | $362.06 | +333.4% | Mar 29, 2023 |
| Morgan Stanley | Alex Straton | $387 | $315.24 | +294.7% | Mar 28, 2023 |
| Oppenheimer | Analyst unavailable | $400 | $319.1 | +307.9% | Feb 8, 2023 |
| Citigroup | Analyst unavailable | $350 | $314.37 | +256.9% | Jan 13, 2023 |
| Argus Research | Analyst unavailable | $350 | $309.48 | +256.9% | Jan 11, 2023 |
| BMO Capital | Simeon Siegel | $304 | $309.48 | +210.0% | Jan 10, 2023 |
| Wells Fargo | Ike Boruchow | $380 | $329.1 | +287.5% | Jan 6, 2023 |
| Piper Sandler | Analyst unavailable | $385 | $320.98 | +292.6% | Jan 5, 2023 |
| Barclays | Analyst unavailable | $445 | $326.39 | +353.8% | Dec 12, 2022 |
| Piper Sandler | Analyst unavailable | $390 | $326.73 | +297.7% | Dec 9, 2022 |
| Goldman Sachs | Analyst unavailable | $431 | $324.22 | +339.5% | Dec 9, 2022 |
| Wells Fargo | Analyst unavailable | $360 | $324.2 | +267.1% | Dec 9, 2022 |
| Raymond James | Rick Patel | $438 | $324.4 | +346.7% | Dec 9, 2022 |
| Cowen & Co. | Analyst unavailable | $542 | $376.93 | +452.7% | Dec 5, 2022 |
| Credit Suisse | Analyst unavailable | $465 | $385.99 | +374.2% | Dec 5, 2022 |
| Citigroup | Analyst unavailable | $400 | $385.99 | +307.9% | Dec 5, 2022 |
| UBS | Analyst unavailable | $395 | $382.86 | +302.8% | Dec 2, 2022 |
| Piper Sandler | Abbie Zvejnieks | $350 | $289.85 | +256.9% | Oct 11, 2022 |
| Morgan Stanley | Alex Straton | $343 | $314.31 | +249.8% | Sep 2, 2022 |
| Deutsche Bank | Gabriella Carbone | $434 | $314.17 | +342.6% | Sep 2, 2022 |
| Piper Sandler | Abbie Zvejnieks | $320 | $314.17 | +226.3% | Sep 2, 2022 |
| Goldman Sachs | Brooke Roach | $383 | $314.17 | +290.6% | Sep 2, 2022 |
| Goldman Sachs | Brooke Roach | $365 | $308.88 | +272.2% | Aug 2, 2022 |
| Jefferies | Randal Konik | $200 | $282.93 | +104.0% | Jul 11, 2022 |
| Morgan Stanley | Kimberly Greenberger | $315 | $290.93 | +221.2% | Jun 28, 2022 |
| Robert W. Baird | Mark Altschwager | $450 | $291.6 | +358.9% | Jun 13, 2022 |
| Bernstein | Jamie Merriman | $300 | $300.8 | +205.9% | Jun 6, 2022 |
| Morgan Stanley | Kimberly Greenberger | $303 | $299.2 | +209.0% | Jun 3, 2022 |
| Telsey Advisory | Dana Telsey | $470 | $300.8 | +379.3% | Jun 3, 2022 |
| Deutsche Bank | Gabriella Carbone | $427 | $300.8 | +335.4% | Jun 3, 2022 |
| BTIG | Camilo Lyon | $420 | $300.8 | +328.3% | Jun 3, 2022 |
| Wells Fargo | Ike Boruchow | $345 | $300.8 | +251.8% | Jun 3, 2022 |
| Guggenheim | Robert Drbul | $475 | $302.58 | +384.4% | Jun 2, 2022 |
| Goldman Sachs | Brooke Roach | $456 | $302.58 | +365.0% | Jun 2, 2022 |
| Guggenheim | Robert Drbul | $475 | $302.58 | +384.4% | Jun 2, 2022 |
| Argus Research | John Staszak | $310 | $274.04 | +216.1% | May 23, 2022 |
| Oppenheimer | Brian Nagel | $440 | $363.26 | +348.7% | Apr 29, 2022 |
| Wedbush | Analyst unavailable | $430 | $362.43 | +338.5% | Apr 29, 2022 |
| Deutsche Bank | Gabriella Carbone | $423 | $357.7 | +331.4% | Apr 26, 2022 |
| Truist Financial | Beth Reed | $495 | $361.97 | +404.8% | Apr 25, 2022 |
| Morgan Stanley | Analyst unavailable | $339 | $384.86 | +245.7% | Apr 21, 2022 |
| Cowen & Co. | John Kernan | $507 | $390.78 | +417.0% | Apr 16, 2022 |
| Truist Financial | Beth Reed | $390 | $368.74 | +297.7% | Apr 11, 2022 |
| Barclays | Adrienne Yih | $441 | $384.18 | +349.7% | Apr 4, 2022 |
| MKM Partners | Roxanne Meyer | $447 | $376.92 | +355.8% | Mar 30, 2022 |
| BTIG | Camilo Lyon | $491 | $376.92 | +400.7% | Mar 30, 2022 |
| Evercore ISI | Omar Saad | $450 | $376.92 | +358.9% | Mar 30, 2022 |
| Deutsche Bank | Gabriella Carbone | $428 | $376.92 | +336.5% | Mar 30, 2022 |
| Bank of America Securities | Lorraine Hutchinson | $450 | $376.92 | +358.9% | Mar 30, 2022 |
| Morgan Stanley | Kimberly Greenberger | $300 | $376.92 | +205.9% | Mar 30, 2022 |
| Guggenheim | Robert Drbul | $475 | $343.97 | +384.4% | Mar 29, 2022 |
| J.P. Morgan | Matthew Boss | $450 | $343.97 | +358.9% | Mar 29, 2022 |
| Bernstein | Aneesha Sherman | $260 | $289.24 | +165.1% | Mar 14, 2022 |
| Robert W. Baird | Mark Altschwager | $425 | $289.24 | +333.4% | Mar 14, 2022 |
| Jefferies | Randal Konik | $340 | $336.37 | +246.7% | Feb 6, 2022 |
| BTIG | Camilo Lyon | $489 | $328.98 | +398.7% | Jan 16, 2022 |
| Piper Sandler | Erinn Murphy | $480 | $352.72 | +389.5% | Jan 12, 2022 |
| UBS | Jay Sole | $430 | $346.75 | +338.5% | Jan 11, 2022 |
| Telsey Advisory | Dana Telsey | $470 | $346.75 | +379.3% | Jan 11, 2022 |
| Stifel Nicolaus | Jim Duffy | $500 | $348.43 | +409.9% | Jan 10, 2022 |
| B.Riley Financial | Susan Anderson | $487 | $355.21 | +396.6% | Jan 7, 2022 |
| Argus Research | John Staszak | $530 | $403.75 | +440.5% | Dec 13, 2021 |
| Oppenheimer | Brian Nagel | $520 | $426.55 | +430.3% | Sep 17, 2021 |
Track every rating change on LULU the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationLululemon Athletica Inc., alongside its subsidiaries, specializes in the design, global distribution, and retail of athletic apparel and accessories for both women and men. Its business operations are structured into two main divisions: company-owned retail establishments and direct-to-consumer sales. The firm's offerings encompass a range of clothing such as pants, shorts, tops, and jackets, all crafted for promoting a healthy lifestyle and facilitating athletic endeavors. These activities span yoga, running, training, and other physically demanding pursuits. Beyond apparel, Lululemon also supplies fitness-related accessories and a selection of footwear. Customers can acquire Lululemon products through numerous channels. These include a global network of corporate-managed stores, outlet locations, and seasonal warehouse sales.…
Historical context
All LULU earningsConsumer Cyclical peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| LEN-B Lennar Corporation | FY2026 Q3 · Calendar Q3 2026 | — | — | Lennar: Efficiency Gains Offset Housing-Market Pressures |
| LEN Lennar Corporation | FY2026 Q3 · Calendar Q3 2026 | — | -4.1% | Lennar Holds Volume Guidance as Margins Improve Despite Housing Headwinds |
| TCOM Trip.com Group Limited | FY2026 Q2 · Calendar Q3 2026 | +22.3% | +3.0% | Trip.com pairs international growth with heavier AI investment |
| CASY Casey's General Stores, Inc. | FY2027 Q1 · Calendar Q3 2026 | +8.7% | -14.2% | Casey's Q1: Prepared Food Drives Growth as Fuel Margins Stay Volatile |
| FIVE Five Below, Inc. | FY2027 Q2 · Calendar Q3 2026 | +20.0% | -1.3% | Five Below raises outlook as its retail flywheel gains momentum |
| BURL Burlington Stores, Inc. | FY2026 Q2 · Calendar Q3 2026 | +35.2% | -7.6% | Burlington raises earnings outlook as value investment supports demand |
Latest beats and misses
Who reports nextBeat on EPS
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
- CASYFY2027 Q1 · September 8, 2026+8.7% EPS-14.2% move
Get the LULU recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-09-04T13:21:42.190399+00:00
- FN2 earnings calendar · 2026-09-20T01:23:12.707946+00:00
- Polygon adjusted daily market bars · 2026-09-20T23:40:47.084885+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-20T23:40:47.082233+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.